A plethora of positives to take out from this announcement, the CSIRO have increased the yield considerably of Flavocide which will reassure potential partners that this product is commercially viable if they are sitting on the fence.
Bio-Gene also own the IP from this collaboration and manufacturing process.
It seems the market believed Virbac was the only agchem company interested in commercialising Bio-Gene's offerings. I look forward to seeing what partnerships and new collaborations come through this year.
- Forums
- ASX - By Stock
- BGT
- Ann: Manufacturing Project with CSIRO Advances to Stage 3
BGT
bio-gene technology ltd
Add to My Watchlist
0.00%
!
1.7¢
Ann: Manufacturing Project with CSIRO Advances to Stage 3, page-9
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
